met

LANZAJET AND KAZMUNAYGAS (KMG) ANNOUNCE KAZAKHSTAN’S FIRST SUSTAINABLE AVIATION FUEL PROJECT PASSES MAJOR MILESTONE AND ADVANCES TO ENGINEERING AND DESIGN PHASE

As part of New York Climate Week, LanzaJet's CEO addressed the President of the Republic of Kazakhstan and met with…

5 days ago

Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints

SHANGHAI, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading…

3 weeks ago

Water Crisis to Water Security: The Art of Living’s Scalable Model for a Water Positive India

BENGALURU, India, Aug. 26, 2025 /PRNewswire/ -- Water is India's lifeline - and its looming crisis. With 80% of the…

1 month ago

Nicox Announces Positive Results from the NCX 470 Phase 3 Denali Trial in Glaucoma Patients

August 21, 2025 01:30 ET  | Source: NICOX SA Press Release Nicox Announces Positive Results from the NCX 470 Phase…

1 month ago

IOC President Coventry visits Singapore for World Aquatics Championships

30 July 2025 - During a three-day visit to the city-state, IOC President Kirsty Coventry attended the World Aquatics Championships; met athletes, partners…

2 months ago

WIKATI Accredited with ICEF Agency Status

HYDERABAD, India, July 8, 2025 /PRNewswire/ -- WIKATI Education Services LLC has been awarded the ICEF Agency Status (IAS), a…

3 months ago

FAIR PLAY MENARINI INTERNATIONAL AWARD, A WAVE OF EMOTIONS MARKS THE 29TH EDITION

FIESOLE, Italy, July 4, 2025 /PRNewswire/ -- A night suspended between history and legend, dedicated to the most authentic values…

3 months ago

OSE Immunotherapeutics met jour linformation sur les procdures en cours

OSE Immunotherapeutics provides an update on ongoing proceedings NANTES, France, July 2, 2025, 8 AM – OSE Immunotherapeutics SA (ISIN:…

3 months ago

Olympic Refuge Foundation unveils plans to step up support for millions of displaced people around the world with new strategy

03 June 2025 - The Olympic Refuge Foundation (ORF) Board met at Olympic House in Lausanne this week, to review the success of…

4 months ago

Novartis Pluvicto demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer

Ad hoc announcement pursuant to Art. 53 LR At interim analysis, PSMAddition trial met its primary endpoint showing statistically significant…

4 months ago